Why the study?
Detecting incipient periodontitis clinically is difficult and dependable biomarkers are lacking, prompting investigation into the clinical utility of salivary periostin as a potential screening tool.
Are salivary periostin levels associated with clinical indicators of periodontitis compared to healthy controls?
Are salivary periostin levels associated with clinical indicators of periodontitis compared to healthy controls?
Salivary periostin levels are significantly lower in patients with periodontitis and correlate negatively with clinical severity markers, suggesting its potential as a non-invasive biomarker for periodontal disease.
Answers are grounded in this paper and cite their sources.
Salivary periostin may indicate periodontitis severity; cross-sectional data leave open its clinical utility as a biomarker.
Background The diagnosis of periodontitis is primarily through clinical and radiographic assessments. However, it is difficult for clinicians to detect incipient periodontitis during the routine clinical assessment. Identifying people at risk for periodontitis and tracking disease development need a dependable biomarker. Currently, no biomarkers meet all the criteria required for an ideal diagnostic test. Therefore, the clinical utility of salivary periostin as a potential screening tool for periodontitis warrants further investigation, particularly through large samples across diverse populations. The present study aimed to investigate salivary periostin levels as a biomarker in individuals with periodontitis and healthy controls. Methods Forty-five patients with generalized periodontitis stage III grade A/B and an equivalent number of periodontally healthy controls were evaluated for plaque index (PI), gingival index (GI), pocket probing depth (PPD), and clinical attachment level (CAL). Unstimulated salivary samples from all subjects were taken, and periostin levels were quantified using an ELISA kit. Results The average salivary periostin levels were 4.63 in the healthy group and 1.24 in the periodontitis group ( P < 0.05). The Spearman coefficient indicated a negative correlation between periostin levels and the gingival index ( r = −0.761), plaque index ( r = −0.780; P < 0.05), probing pocket depth (PPD) ( r = −0.713; P < 0.05) and clinical attachment level (CAL) ( r = −0.713; P < 0.05). Linear regression analysis validated the indirect correlation between salivary periostin levels and clinical indicators (Adjusted R square = 0.947). Conclusions Salivary periostin levels are associated with periodontal disease. Salivary periostin levels indirectly influence as a non-invasive biomarker of periodontitis. The biomarker periostin is effective for evaluating both healthy and diseased periodontium.
No takes yet. Share an insight, caveat, or question.
Padalkar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: